logo
Plus   Neg
Share
Email

Expedia CEO Mark Okerstrom And CFO Alan Pickerill Resign

Expedia Group Inc. (EXPE) said that its chief executive officer Mark Okerstrom and its chief financial officer Alan Pickerill has resigned from the company, effective immediately.

The company said its Chairman Barry Diller and Vice Chairman Peter Kern will oversee the company's executive leadership team, managing day-to-day operations, while the Board determines the long-term leadership of the company.

Eric Hart, the company's Chief Strategy Officer, will serve as acting chief financial officer. Ariane Gorin, who most recently served as President of Expedia Partner Solutions, is being promoted and will have an expanded role as President, Expedia Business Services.

The company said that its board authorized the company to repurchase up to an additional 20 million shares, which is in addition to the 9 million shares available under the company's existing authorization.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry. Graco Inc. (GGG) shares were climbing more than 7 percent in morning trade. Monday after market close, the company had reported a surge in the fourth-quarter earnings to $84.8 million from $73.7 million in the prior year. Earnings per share surpassed analysts' estimates. Sales were up 1 percent to $412.3... Strategy of getting multiple indication approvals for the same drug seems to be paying off for AstraZeneca PLC (AZN), in terms of higher likelihood of approval and improved sales. Besides, the company is realizing value from non-core, mature brands to invest in new drugs, which also seems to be working in its favor.
Follow RTT
>